Roberts Research Institute spins off new company

Guest Contributor
October 12, 2004

The Robarts Research Institute has spun off a company that designs and develops clinical imaging platforms for use by biotechnology and pharmaceutical firms. Biomark Imaging Inc will develop platforms to test new therapies for a range of diseases from osteoporosis to cancer. The business case is being driven by FDA requirements for imaging data as part of clinical trial submissions. Biomark will provide firms with individualized services and results. The company’s president is Dr Osama Sherif...

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.